Amphastar Pharmaceuticals, Inc. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2021-06-04

Reporting Person: Liawatidewi Yakob (EVP Corp Admin Center)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-04	Common Stock	F	264	$18.79	Disposed	54703	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2459	Indirect

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.

F2: Includes 1,394 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2021.

F3: The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.